Close

Amgen (AMGN) Tops Q3 EPS by 23c

October 25, 2017 4:03 PM EDT

Amgen (NASDAQ: AMGN) reported Q3 EPS of $3.34, $0.23 better than the analyst estimate of $3.11. Revenue for the quarter came in at $5.77 billion versus the consensus estimate of $5.76 billion.

GUIDANCE:

Amgen sees FY2017 EPS of $12.50-$12.70, versus the consensus of $12.57. Amgen sees FY2017 revenue of $22.7-23 billion, versus the consensus of $22.87 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings